On July 11, 2017, the German Federal Supreme Court announced that it had affirmed the decision of the Federal Patent Court last year to issue a compulsory license allowing Merck to continue selling its HIV drug, raltegravir (marketed as Isentress).
On Thursday afternoon, 6 July 2017, the 26th session of the WIPO Standing Committee on the Law of Patents (SCP), chaired by Ms. Bucura Ionescu (Romania) reached agreement on future work on the following issues: i) Exceptions and Limitations to Patent Rights, ii) Quality of Patents, including Opposition Systems, iii) Patents and Health, iv) Confidentiality of Communications between Clients and Their Patent Advisors and v) Transfer of Technology. Continue Reading
Senator Angus King proposed an amendment to National Defense Authorization Act (NDAA) that would require the Department of Defense (DoD) to authorize third parties to use inventions that benefited from DoD research funding, when prices exceed the median price charge in the seven largest economies with per capita incomes at least half the per capita income in the United States.
Today at WIPO, KEI hosted a side event to discuss the ability of countries to deny injunctions in patent infringement cases.
On July 4th, 2017, Andrew Goldman delivered Knowledge Ecology International’s intervention on patents at health at the 26th session of the WIPO Standing Committee on the Law of Patents (SCP).
KEI Statement on Patents and Health
WIPO Standing Committee on the Law of Patents – 26th SessionJuly 4th, 2017
Since the African Group and Development Agenda Group first tabled their proposal on a work program on patents and health in May 2011, much has happened.